<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36078" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Generalized Pustular Psoriasis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mirza</surname>
            <given-names>Huma A.</given-names>
          </name>
          <aff>King Edward Medical Un/Mayo Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Badri</surname>
            <given-names>Talel</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kwan</surname>
            <given-names>Eddie</given-names>
          </name>
          <aff>Uniformed Services University of the Health Sciences</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Huma Mirza declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Talel Badri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Eddie Kwan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36078.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Generalized pustular psoriasis (GPP) is a rare, severe form of psoriasis marked by the presence of sterile pustules across large areas of the skin. This condition most commonly affects individuals aged between 40 and 59, though cases in infants and juveniles are reported. The condition may occur with or without plaque psoriasis and is often linked to metabolic syndrome and polyarthritis. GPP can present with systemic symptoms, requiring extensive evaluation to rule out infectious causes and involve a comprehensive examination of the skin, scalp, nails, and hair to ensure accurate diagnosis.</p>
        <p>Participants in this course gain a deeper understanding of the pathophysiology, clinical presentation, and diagnostic approach to generalized pustular psoriasis, including how to differentiate it from infectious conditions. The course emphasizes the importance of interprofessional collaboration, particularly among dermatologists, rheumatologists, and primary care providers, to ensure a thorough evaluation and coordinated treatment plan. This approach enhances patient outcomes by addressing both the cutaneous and systemic manifestations of the disease, improving overall management and care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess&#x000a0;the history and physical exam findings typically seen in patients with generalized pustular psoriasis.</p></list-item><list-item><p>Differentiate generalized pustular psoriasis from other pustular and infectious skin conditions.</p></list-item><list-item><p>Identify the clinical signs and symptoms of generalized pustular psoriasis to ensure early diagnosis.</p></list-item><list-item><p>Communicate&#x000a0;the need for a well-integrated, interprofessional team approach to improve care for patients with generalized pustular psoriasis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36078&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36078">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-36078.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pustular psoriasis is a&#x000a0;rare and extreme form of psoriasis characterized by the appearance of sterile pustules, which can take many patterns.&#x000a0;All the main pathological features of the disease are accentuated. Generalized pustular psoriasis is clinically heterogeneous in its age at onset, precipitants, severity, and natural history. Many overlapping clinical entities are recognized. There is a relationship between these entities and plaque psoriasis, as some individuals may have episodes of plaque psoriasis preceding or following the generalized pustular psoriasis, but in others, generalized pustular psoriasis occurs as the sole phenotype without plaque psoriasis&#x000a0;at any time (See&#x000a0;<bold>Image.</bold>&#x000a0;Pustular Psoriasis).<xref ref-type="bibr" rid="article-36078.r1">[1]</xref><xref ref-type="bibr" rid="article-36078.r2">[2]</xref><xref ref-type="bibr" rid="article-36078.r3">[3]</xref></p>
      </sec>
      <sec id="article-36078.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Factors that may trigger or exacerbate generalized pustular psoriasis include:&#x000a0; &#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p><bold>Infections:&#x000a0;</bold>Viral or bacterial infections are common exacerbating factors, reported in 12 of 16 patients with known generalized pustular psoriasis in&#x000a0;1 series.</p>
          </list-item>
          <list-item>
            <p><bold>Drugs:&#x000a0;</bold>The most important drug provocation is corticosteroids. There is substantial evidence that withdrawal of systemic corticosteroid therapy can precipitate generalized pustular psoriasis, and topical therapy with potent corticosteroids under occlusion has also been implicated. There are reports of the induction of disease on withdrawal of ciclosporin. Other systemic drugs have occasionally been implicated, including terbinafine, propranolol, bupropion, lithium, phenylbutazone, salicylates,&#x000a0;and potassium iodide. Coal tar and dithranol may provoke pustulation if applied injudiciously when the disease is unstable.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Psychological stress:&#x000a0;</bold>Many individuals report deterioration at times&#x000a0;of psychological stress.</p>
          </list-item>
          <list-item>
            <p><bold>Hypocalcemia:&#x000a0;</bold>Hypocalcemia may arise due to generalized pustular psoriasis, but triggering of active disease by hypocalcemia caused by hypoparathyroidism has also been reported.</p>
          </list-item>
          <list-item>
            <p><bold>Pregnancy:&#x000a0;</bold>Pregnancy has been recognized as&#x000a0;1 of the risk factors.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36078.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Characteristics of the epidemiology of generalized pustular psoriasis include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Incidence and prevalence:&#x000a0;</bold>Generalized pustular psoriasis is rare. The annual incidence and prevalence in the French population have been estimated at least 0.64 and 1.76 per million, respectively. The prevalence in Japan has been estimated at 7.46 per million.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Age at onset:&#x000a0;</bold>The incidence peaks in those aged between 40 and 59, but infantile and juvenile cases are also reported. The age at onset tends to be earlier in those with pure generalized pustular psoriasis without plaque psoriasis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Gender:&#x000a0;</bold>In some published study results, women outnumber men in a ratio of about 2 to 1, which is inconsistent in all cohorts.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Associated diseases:&#x000a0;</bold>Inflammatory polyarthritis is common. In&#x000a0;1 series, one-third of patients were eventually affected. The metabolic syndrome is also frequently associated; in&#x000a0;1 large series, the reported co-morbidities included obesity (43%), hypertension (26%), dyslipidemia (26%), and diabetes (24%).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36078.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Deleterious germline mutations in&#x000a0;<italic toggle="yes">IL36RN&#x000a0;</italic>have been reported in familial and sporadic generalized pustular psoriasis in populations from the United Kingdom, Germany, Tunisia, Malaysia, China, and Japan. Mutations differ between populations, with evidence of a founder effect; in Europeans, the most common mutation in <italic toggle="yes">IL36RN</italic> results in the substitution p.Ser113Leu and is present in 0.03% of the healthy European population.&#x000a0;Generalized pustular psoriasis patients with&#x000a0;<italic toggle="yes">IL36RN</italic> mutations are&#x000a0;more likely to have early-onset disease and a systemic inflammatory response.<xref ref-type="bibr" rid="article-36078.r4">[4]</xref><xref ref-type="bibr" rid="article-36078.r5">[5]</xref></p>
        <p><italic toggle="yes">IL36RN</italic> encodes the IL-36 receptor antagonist (IL36-Ra), expressed primarily in the skin, and is the antagonist of&#x000a0;3 pro-inflammatory cytokines of the interleukin (IL)-1 family (IL-36 alpha, beta, and gamma). These cytokines activate signaling pathways, such as NF-kB and mitogen-activated protein kinase, and are interrelated by Th17 cytokines and tumor necrosis factor-alpha. IL-36 cytokines are also overexpressed in plaque psoriasis skin, consistent with the concept that abnormal IL-36 signaling has a significant role in establishing cutaneous inflammation but presumably by a different mechanism than in generalized pustular psoriasis. There are occasional reports of mutations in <italic toggle="yes">CARD14,&#x000a0;</italic>particularly in those with coexistent plaque psoriasis.</p>
      </sec>
      <sec id="article-36078.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In acute, generalized pustular psoriasis, there is intense inflammation. The earliest infiltrate is lymphocytic. Intense papillary and epidermal edema cause spongiosis. The arrival of masses of neutrophils leads to spongiform pustule formation (pustules of Kogoj) and abscesses that quickly become macroscopic. There is acanthosis with elongation of rete ridges. The stratum corneum soon becomes a parakeratotic, and subcorneal pustule is shed as epidermal turnover is accelerated; similar features are seen in subacute as acute patterns but in a less intense form.</p>
      </sec>
      <sec id="article-36078.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In the acute setting, the patient complains of a burning sensation in the skin associated with some pain, usually without any triggering factor. Fever and general debility accompany the appearance of pustules. A few individuals complain of joint pains.<xref ref-type="bibr" rid="article-36078.r6">[6]</xref><xref ref-type="bibr" rid="article-36078.r7">[7]</xref><xref ref-type="bibr" rid="article-36078.r8">[8]</xref></p>
        <p>Following are the clinical subtypes based on morphology and natural history:&#x000a0; &#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>The most acute and extreme form of pustular psoriasis is von Zumbusch; thecondition has been given this name after Leo von Zumbusch who described the disease in&#x000a0;2 siblings, caused by some topical treatment. Diagnosis is based on clinical features, abnormal laboratory studies (leukocytosis, elevated erythrocyte sedimentation rate, or C-reactive protein), and histopathological evidence of spongiform pustules.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Early onset plaque psoriasis may develop into pustular psoriasis after years, the cause usually being steroids or any other environmental factor, or the onset may be de novo, usually after an infection. In either form, the earliest symptom is a burning sensation in the skin, which becomes dry and tender. These danger signs, not found in all cases, are followed by a sudden onset of high fever and severe malaise. Pre-existing lesions develop into minute pustules. Worsening of erythema occurs, and pustules spread to involve the previously normal skin, mostly the flexures and genital regions. Pustules may be in the form of discrete pustules, lakes of pus, circinate lesions, erythematous plaques covered with pustules, or a generalized erythroderma. Pustules appear in a series, and dried pustules start exfoliating. The nail changes include thickening and subungual areas of pus. The oral mucosa and tongue may also be involved. The disease process may resolve within a few days or weeks; psoriasis can revert to its normal state, or erythroderma can develop.<italic toggle="yes">&#x000a0;</italic></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A rare subacute form represents generalized pustular psoriasis in infancy and early childhood. The disease starts as discrete areas of erythema which become elevated. Pustules appear peripherally on the advancing edge, becoming dry and shedding in the form of scales as the lesion gradually progresses. There are no accompanying systemic symptoms.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Impetigo herpetiformis represents widespread pustular psoriasis occurring in pregnancy. Onset is usually in the third trimester of pregnancy but may be earlier and has been documented in the first month of pregnancy and on the first day of the puerperium. The disease often persists until the child is born and may last after childbirth and is characterized by salient features of generalized pustular psoriasis, usually starting from flexural surfaces as symmetrical, confluent areas of pustulation. The lesions begin in the groin region and other flexures, with small pustules appearing on inflamed skin. These spread radially, become dry in the center, or form plaques that may become widespread and leave a reddish-brown pigmentation as they heal. The tongue, oral cavity, and even the esophagus may be involved, with erosions following pustules.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Complications include delirium, gastrointestinal upset, tetany, cardiac or renal failure, and ultimately death. The risks of placental insufficiency include stillbirth, neonatal death, or fetal abnormalities and are directly proportional to the severity and chronicity of the disease. The disease recurs in the next pregnancies and on subsequent use of oral contraceptives.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In 30% of cases, the onset of the disease occurs in the first year of life. The disease may start in the first few weeks of life and may be present congenitally.</p>
          </list-item>
        </list>
        <p>In infants, systemic symptoms are often absent, and the disease may require no treatment. Pustular psoriasis may be limited to flexural areas, such as the neck, for prolonged periods. More severe forms with systemic involvement require active management. In children, the age of onset is mostly seen in those aged between 2 and 10 years. The lesions may be of von Zumbusch pattern, but annular and circinate forms are more common. Attacks may settle within a few days, but relapses with inflammatory episodes may occur. In older children, the disease resembles that in adults and may take any pattern.</p>
      </sec>
      <sec id="article-36078.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The following laboratory studies help in the evaluation of the disease:&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Elevated erythrocyte sedimentation rate</p>
          </list-item>
          <list-item>
            <p>Elevated C-reactive protein levels&#x000a0;</p>
          </list-item>
          <list-item>
            <p>An absolute lymphopenia at the onset, quickly followed by polymorphonuclear leukocytosis</p>
          </list-item>
          <list-item>
            <p>Abnormally low plasma albumin, zinc, and calcium&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Deranged lipid profile</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36078.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Generalized pustular psoriasis is treated on the following lines:</p>
        <p>
<bold>Conservative Treatment</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Encourage fluid and protein intake</p>
          </list-item>
          <list-item>
            <p>Monitor input/output</p>
          </list-item>
          <list-item>
            <p>Treat infection, if any, with antibiotic</p>
          </list-item>
          <list-item>
            <p>Terminate pregnancy if there is a risk to maternal life</p>
          </list-item>
          <list-item>
            <p>Prevent hypothermia</p>
          </list-item>
        </list>
        <p>
<bold>Topical</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bland emollients</p>
          </list-item>
          <list-item>
            <p>Diluted corticosteroids&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Systemic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>First line</bold>
<list list-type="bullet"><list-item><p>Acitretin (not given in pregnancy) in a dose of 1 mg/kg/day</p></list-item><list-item><p>Ciclosporin, 3.5 to 5 mg/kg/day</p></list-item><list-item><p>Methotrexate, 0.2 to 0.4 mg/kg/day</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Second line</bold>
<list list-type="bullet"><list-item><p>Infliximab</p></list-item><list-item><p>Adalimumab</p></list-item><list-item><p>Etanercept</p></list-item><list-item><p>Prednisolone (only in special conditions, eg, complications)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Third line</bold>
<list list-type="bullet"><list-item><p>Anakinra&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36078.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis is that of widespread nonfollicular pustules. In the acute phase, fever, leukocytosis, and elevated inflammatory markers may lead to a mistaken diagnosis of systemic infection, sometimes leading to a counterproductive discontinuation of immunosuppressive treatment. Acute generalized exanthematous pustulosis&#x000a0;is a febrile rash showing erythema and pustules. Histopathology shows neutrophilic exoserosis&#x000a0;with intraepidermal or subcorneal pustules, edema of the papillary dermis, as well as neutrophilic and eosinophilic dermal infiltrate.</p>
        <p>Drugs or infections trigger acute generalized exanthematous pustulosis and generally&#x000a0;resolves in&#x000a0;2 weeks following the&#x000a0;triggering factor cessation. Subcorneal pustular dermatosis of Sneddon and Wilkinson is an erythematous&#x000a0;and pustular dermatosis of the trunk and intertriginous areas, and its link to pustular psoriasis remains controversial. IgA pemphigus can mimic generalized pustular psoriasis, but histological and immunofluorescence testing distinguishes between them. The wasting, glossitis, and anemia associated with the migratory necrolytic eruption of glucagonoma should allow differentiation.&#x000a0;</p>
      </sec>
      <sec id="article-36078.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In the absence of effective treatment, death can occur in the acute stage. The prognosis is good for subacute annular and circinate generalized pustular psoriasis and, consequently, for disease in children. Amongst generalized pustular psoriasis, the prognosis is better when there is a clear trigger, exemplified by generalized pustular psoriasis of pregnancy. Generalized pustular psoriasis developing from acrodermatitis continua of Hallopeau seems to have the worst prognosis.<xref ref-type="bibr" rid="article-36078.r9">[9]</xref><xref ref-type="bibr" rid="article-36078.r10">[10]</xref></p>
      </sec>
      <sec id="article-36078.s12" sec-type="Complications">
        <title>Complications</title>
        <p>In the acute phase, the individual is systemically unwell.&#x000a0;The complications that can manifest with&#x000a0;generalized pustular psoriasis are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypovolemia and oligaemia can cause acute kidney injury&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypoalbuminaemia may be profound because of a sudden loss of plasma protein into the tissues and intestinal malabsorption</p>
          </list-item>
          <list-item>
            <p>Hypocalcemia may occur as a consequence of hypoalbuminemia</p>
          </list-item>
          <list-item>
            <p>Liver enzymes may have abnormalities</p>
          </list-item>
          <list-item>
            <p>Cholestatic jaundice as a consequence of neutrophilic cholangitis</p>
          </list-item>
          <list-item>
            <p>Acute respiratory distress syndrome, although rare</p>
          </list-item>
          <list-item>
            <p>Staphylococcal infection may complicate the disease process</p>
          </list-item>
          <list-item>
            <p>Hair loss from all areas of the body if the disease gets prolonged</p>
          </list-item>
          <list-item>
            <p>Telogen effluvium may follow 2 to 3 months after the height of the illness</p>
          </list-item>
          <list-item>
            <p>Amyloidosis, a rare late complication</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36078.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Psoriasis, in general, is managed by the dermatologist, but the primary care clinician follows most patients. One rare form of psoriasis is pustular psoriasis, characterized by the appearance of sterile pustules, which can take many patterns. All the main pathological features of the disease are accentuated. Generalized pustular psoriasis is clinically heterogeneous in its age at onset, precipitants, severity, and natural history. The treatment is identical to the usual psoriasis, but death can occur in the acute stage without effective treatment. The prognosis is good for subacute annular and circinate generalized pustular psoriasis and, consequently, for disease in children. Among generalized pustular psoriasis, the prognosis is better when there is a clear trigger, exemplified by generalized pustular psoriasis of pregnancy. Generalized pustular psoriasis developing from acrodermatitis continua of Hallopeau seems to have the worst prognosis.</p>
      </sec>
      <sec id="article-36078.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36078&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36078">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/generalized-pustular-psoriasis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=36078">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36078/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36078">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-36078.s15">
        <fig id="article-36078.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pustular Psoriasis.&#x000a0;Pustular psoriasis is a rare and extreme form of psoriasis characterized by the appearance of sterile pustules, which can take many patterns. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pustular__psoriasis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-36078.s16">
        <title>References</title>
        <ref id="article-36078.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kusakabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamanishi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis.</article-title>
            <source>Dis Markers</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9758473</fpage>
            <pub-id pub-id-type="pmid">30647802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peccerillo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Odorici</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ciardo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pellacani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of generalized pustular psoriasis by reflectance confocal microscopy.</article-title>
            <source>Skin Res Technol</source>
            <year>2019</year>
            <month>May</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>402</fpage>
            <page-range>402-403</page-range>
            <pub-id pub-id-type="pmid">30614082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akiyama</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Early-onset generalized pustular psoriasis is representative of autoinflammatory keratinization diseases.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>143</volume>
            <issue>2</issue>
            <fpage>809</fpage>
            <page-range>809-810</page-range>
            <pub-id pub-id-type="pmid">30606494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meier-Schiesser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Feldmeyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mellett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Yerly</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Navarini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yawalkar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Contassot</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis.</article-title>
            <source>J Invest Dermatol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>139</volume>
            <issue>4</issue>
            <fpage>848</fpage>
            <page-range>848-858</page-range>
            <pub-id pub-id-type="pmid">30395846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population.</article-title>
            <source>Br J Dermatol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>180</volume>
            <issue>2</issue>
            <fpage>425</fpage>
            <page-range>425-426</page-range>
            <pub-id pub-id-type="pmid">30387497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Twelves</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mostafa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dand</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Farkas</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Irvine</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Oon</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Kingo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>K&#x000f6;ks</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mrowietz</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Puig</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Tanew</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Torz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Trattner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Valentine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wahie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bata-Cs&#x000f6;rg&#x00151;</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Szell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>CEM</given-names>
              </name>
              <name>
                <surname>Burden</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Choon</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Navarini</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Capon</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic differences between pustular psoriasis subtypes.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>143</volume>
            <issue>3</issue>
            <fpage>1021</fpage>
            <page-range>1021-1026</page-range>
            <pub-id pub-id-type="pmid">30036598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>TF</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.</article-title>
            <source>J Dermatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>1353</fpage>
            <page-range>1353-1356</page-range>
            <pub-id pub-id-type="pmid">30230584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boehner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Navarini</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Eyerich</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.</article-title>
            <source>Exp Dermatol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>1067</fpage>
            <page-range>1067-1077</page-range>
            <pub-id pub-id-type="pmid">29852521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Georgakopoulos</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ighani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Systemic Monotherapy Treatments for Generalized Pustular Psoriasis: A Systematic Review.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2018</year>
            <season>Nov/Dec</season>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>591</fpage>
            <page-range>591-601</page-range>
            <pub-id pub-id-type="pmid">29707979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36078.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoegler</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Handler</surname>
                <given-names>MZ</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Generalized pustular psoriasis: a review and update on treatment.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>10</issue>
            <fpage>1645</fpage>
            <page-range>1645-1651</page-range>
            <pub-id pub-id-type="pmid">29573491</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
